Neuros Medical

Neuros Medical is a commercial-stage private company that has successfully brought an innovative neuromodulation device to market for a significant unmet need. Its Altius System, approved by the FDA, delivers targeted electrical nerve block to provide on-demand relief from chronic phantom and residual limb pain. The device demonstrated compelling clinical results in its pivotal QUEST study, showing substantial pain reduction and improvements in patient quality of life, walking, and sleep, while also reducing opioid reliance. The company is positioned in the high-growth neuromodulation and chronic pain management markets.

High-frequency direct electrical nerve block for on-demand, patient-controlled neuromodulation to block peripheral pain signals.

The Altius System is first-in-class for its specific mechanism, but it competes indirectly in the chronic pain neuromodulation market against large players like Abbott, Boston Scientific, and Medtronic who offer spinal cord and peripheral nerve stimulation. It also competes with pharmacological therapies, physical interventions, and other non-invasive devices for post-amputation pain management.